Turbine
Jane Rhodes serves as the Chief Executive Officer of AstronauTx since September 2024, while also holding the position of Non Executive Director at Turbine and Chairperson at Pheno Therapeutics Ltd. Since November 2017, Jane Rhodes has been a Co-Founder and Board Observer of Qr8 Health, which specializes in developing digital assessment tools for patient-centric data collection. Additional experience includes serving as President and Chief Business Officer at Verge Genomics from September 2019 to September 2024, and as Vice President of Business Development and Corporate Strategy at FORMA Therapeutics, Inc. from November 2017 to June 2019. Jane Rhodes has an extensive background at Biogen, where roles included Senior Director and Director in various capacities from 2007 to 2017, and prior positions at Eisai and Amgen. Jane Rhodes holds a PhD in Neuropharmacology and an MBA in Business Administration, both from The University of Manchester, along with a BSc in Physiology and Pharmacology from the same institution.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Turbine
5 followers
Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer.